Cogent Biosciences, Inc.
- Last sale
- Nov 12, 2026 · -0.85%
- Market cap
- $5.07B
- 173.99M shares
- Filings
- 616
FY 2020−65.0% FY20 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+217.8% FY25 yoy
- $5.07B
- —
- —
- 9.8×
- -5.25%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2020 | 2020-12-31 | $7,871,000 | reported | |
| FY 2019 | 2019-12-31 | $22,499,000 | reported | |
| FY 2018 | 2018-12-31 | $9,734,000 | reported | |
| FY 2017 | 2017-12-31 | $8,360,000 | reported |
Segments
Segments
LineFY2025ShareChange
Late-stage Development$120.06M—−0.7%
R&D Personnel Related$64.04M—+36.1%
Stock-Based Compensation Expense$46.08M—+16.0%
Other Operational Infrastructure and Advisory Support$40.43M—+50.4%
Early-stage, Preclinical and Discovery Programs$40.11M—+42.5%
Research and Development Software, Facilities and Other Strategic Support$20.09M—+85.8%
Depreciation Expense$2.56M—+4.7%
Total-$333.36M
Pharmaceutical preparations
Cogent Biosciences, Inc. is the 53rd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
MANEVeradermics, Inc———$5.7BERASErasca, Inc.———$5.5BPTCTPTC Therapeutics, Inc.$1.7B114.5%39.4%$5.3BLQDALiquidia Corp$158.3M1,031.2%43.5%$5.2BDNTHDianthus Therapeutics, Inc.$2.0M67.3%7,973.3%$5.2B
COGTCogent Biosciences, Inc. (this company)———$5.1B
TVTXTravere Therapeutics, Inc.$490.7M110.5%5.2%$5.0BAMRNAmarin Corp Plcuk$213.6M6.5%18.2%$4.9BIONSIonis Pharmaceuticals Inc$943.7M33.8%40.4%$4.5BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Cogent Biosciences, Inc. · CIK 1622229 · Engraved from SEC EDGAR